Den europeiske union - finsk - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellituksen hoito.

Den europeiske union - finsk - EMA (European Medicines Agency)

viatris limited - glargininsuliini - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellituksen hoito aikuisilla, nuorilla ja yli 2-vuotiailla lapsilla.

Den europeiske union - finsk - EMA (European Medicines Agency)

eli lilly nederland b.v. - glargininsuliini - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellituksen hoito aikuisilla, nuorilla ja yli 2-vuotiailla lapsilla.

Den europeiske union - finsk - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - diabeetilla käytettävät lääkkeet - diabetes mellitus, johon tarvitaan insuliinin hoitoa. insulin human winthrop rapid soveltuu myös hyperglykeemisen kooman ja ketoasidoosin hoitoon sekä diabetes mellituspotilaille ennalta, sisäisestä ja postoperatiivisesta vakautumisesta.

USA - engelsk - NLM (National Library of Medicine)

newton laboratories, inc. - silver (unii: 3m4g523w1g) (silver - unii:3m4g523w1g), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), giant puffball (unii: i6839y031a) (giant puffball - unii:i6839y031a), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), chionanthus virginicus bark (unii: s9y4b22u2e) (chionanthus virginicus bark - unii:s9y4b22u2e), gaulth - silver 15 [hp_x] in 1 ml - diabetes    formulated for symptoms associated with pancreatic dysfunction such as excessive thirst or hunger, polyuria, neuralgia and slow-healing wounds.      formulated for symptoms associated with pancreatic dysfunction such as excessive thirst or hunger, polyuria, neuralgia and slow-healing wounds.

USA - engelsk - NLM (National Library of Medicine)

newton laboratories, inc. - silver (unii: 3m4g523w1g) (silver - unii:3m4g523w1g), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), giant puffball (unii: i6839y031a) (giant puffball - unii:i6839y031a), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), chionanthus virginicus bark (unii: s9y4b22u2e) (chionanthus virginicus bark - unii:s9y4b22u2e), gaulth - silver 15 [hp_x] in 1 g - diabetes    formulated for symptoms associated with pancreatic dysfunction such as excessive thirst or hunger, polyuria, neuralgia and slow-healing wounds.      formulated for symptoms associated with pancreatic dysfunction such as excessive thirst or hunger, polyuria, neuralgia and slow-healing wounds.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 66082 - diabetes patient management software - the app is a mobile application that is installed on the patient or the caregiver?s personal mobile device. it serves as a display device of the cgm information received from the transmitter and provides the user interface for diabetes management. critical alerts and notifications can be sent to the patient or caregiver via the app.

Kenya - engelsk - Pharmacy and Poisons Board

nabiqasim industries (pvt). ltd. 5th floor commerce centre hasrat mohani road - clomiphene citrate - tablet - clomiphene citrate 50mg - androgens: 3-oxoandrosten-(4) derivatives

Kenya - engelsk - Pharmacy and Poisons Board

medcure healthcare ltd kensia house muranga road - clomiphene 50mg tablets - tablet - clomiphene citrate 50mg - clomifene

Den europeiske union - tysk - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogen bei diabetes verwendet - diabetes mellitus, bei dem eine behandlung mit insulin erforderlich ist. insuman rapid eignet sich auch für die behandlung der hyperglykämischen koma und ketoazidose sowie für die erreichung pre, intra- und postoperativen stabilisierung bei patienten mit diabetes mellitus.